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Abstract 
Cholesterol esterase from Candida cylirzdracea was separated into two fractions, co~pondi~g to a dimeric and a monomers form. Fingerprint 
analysis after lysine cleavages hows identical patterns, suggesting lack of primary differences. Crystals obtained from the two proteins differ and 
suggest he ~~ibjlity of an equ~I~b~~ between the two forms, influenced by the substrate cholesterol Iinoleate, which appears to stabilize the more 
active, dimeric form. All crystals have dimers as the asymmetric unit. The primary structure of the enzyme was dete~ined at the peptide Ievel and 
shows only one difference, Leu-350 instead of Ile, from a DNA-deduced amino acid sequence, and conservation of features typical for cholesterol 
esterases characterized. 
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1, Introduction 
Cholesterol and cholesterol esters are major constitu- 
ents of intimal atherosclerotic lesions [ 13, and their ratio 
is influenced by cholesterol esterases. These enzymes 
occur in multiple forms in many organisms, including 
apparent dimers and monomers, reported not only in 
mammals [Z] but also in the enzymes from completely 
different sources, e.g. yeasts [3]. In addition, the enzyme 
is represented by multiple genomic sequences, and five 
of these have recently been determined for the asporo- 
genie yeast Candida cylindracea [4-61. These enzymes are 
members of a large enzyme family of serine hydrolases, 
including acetylcholine esterases, neutral lipases, many 
other esterases, and also non-hydrolytic proteins (e.g. 
[7-lo]). Three-dimensional structures are known for sev- 
eral of these enzymes, including a Torpedo acetylcholine 
esterase [ll] and four lipases with highly different ori- 
gins, from human pancreas [12], a ~iza~~co~ [13], a 
Geo~~~c~~~ [14,15] and a Candida 1161. Comparisons of 
sequences and structures upport similarities and suggest 
*Corresponding author: Fax: (46) (8) 337 462. 
functional m~hanisms for the catalysis at the water/lipid 
interface of these enzymes, which often have the catalytic 
triad Ser-His-Glu although the common serine hydrolase 
triad %x-His-Asp also occurs [7-181. 
The Cundida cylind~acea enzymes constitute forms 
much studied [Sal. One of these cholesterol esterases has 
also been crystallized [3] and electron density maps are 
now available [19], soon allowing further analyses of the 
relationships within this divergent enzyme family. For 
interpretation of the crystallographic data, knowledge of 
the primary st~cture and of the relationships between 
the dimeric and monomeric forms of the enzyme is essen- 
tial. 
In this study, we have ~nge~~nted the dimeric and 
monomeric forms of Candida cyl~~dracea cholesterol est- 
erase which crystallize in different crystal classes [3] and 
have also analyzed the entire primary structure of the 
enzyme. After completion of the work, a corresponding 
DNA structure appeared [6], which has a minor differ- 
ence, suggesting ~~roheterogeneity of the enzyme. 
Analysis at the protein level is of additional interest in 
this case, since Candida utilizes one codon (CTG, nor- 
mally for Leu) in a different manner (for Ser) 141. The 
monomeric and dimeric forms of the enzyme appear 
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identical in primary structure. The presence of the sub- 
strate cholesterol linoleate appears to promote a shift 
toward the more active, dimeric form of the enzyme [3]. 
2. Materials and methods 
2.1. Protein 
Commercially available nzyme (B~h~n~r-M~nhe~) with an in- 
itial specific activity of 46 Ulmg was passed through a polyacrylamide 
gel PdDG (Biorad; 6000 Da exclusion limit) desalting column (2.5 x 20 
cm) to eliminate NaCl (pooled fraction, 25 ml). It was then equilibrated 
with 50 mM phosphate buffer, pH 7.3, and separated from contaminat- 
ing bovine albumin (in the commercial preparation) by gel filtration on 
Bio-Gel P-100 (2.5x 100 cm) in 50 mM phosphate buffer, pH 7.3. 
Cholesterol esterase luted as two ba~lin~resolved peaks, a dimer and 
a monomer, at volumes 131 and 16.5 ml, respectively (fractions 1 and 
2; Fig. 1). Each active fraction was pooled and concentrated (Amicon 
concentrator) to 10-15 mglml. The entire purification was performed 
at 4°C. Enzymatic activities were assayed at 500 nm in approximately 
10 mM cholic acid with cholesterol inoleate as described [20]. The 
substrate solution was prepared by dissolving 70 mg of the linoleate in 
2.5 ml Thesit (B~h~nger-Mannheim) and addition of 23 ml of 1 M 
NaCl. 
Crystals of the two active enzyme fractions, corresponding to frac- 
tions 1 and 2 in Fig. 1, were grown by vapour diff~~on of the hanging _ _ 
drop technique at 22’C [3]: The droplets of protein solution were 
stabilized with PEG-3350 and SO mM uhosuhate buffer. DH 7.3. and 
left in vapour diffusion against sealed ^wells containing’ reservoirs of 
825% PEG solution in the same buffer. Crystals appeared within 4-7 
days and continued to grow for two weeks. Before the conditions were 
fully optimized, thin plates of types II and III crystals tended to cluster 
together, but adjustment of the protein concentration made plates 
thicker and largely eliminated tbe clustering problem. 
2.2. Structural analysis 
Redissolved crystals of type II and III were transferred into 6 M 
auanidine hvdr~hio~de. 0.4 M Tris. DH 8.15. 2 mM EDTA. usine a 
centricon fiiter (cut-off lOOO), and v&e carb~~~~ethylat~ ‘with ‘ia- 
belled iodoacetate after reduction with dithiothreitol 1211. The car- 
boxymethylated proteins were cleaved in separate batches with prote- 
olytic enzymes, Achromabucter Lys-specific protease (Waco Chemicals, 
Neuss, Germany), Staphylococcai Glu-C-specific and Pseudemonas N- 
Asp-specific proteases (from Boehringer-Mannheim), all in 0.1 M am- 
monium bicarbonate, 1.5 M urea, 37’C, for 4-20 h. Soluble peptides 
obtained were separated by HPLC on Vydac G-8 or on UltroPac TSK 
ODS-12OT C-18. Samples were also digested with CNBr in 70% formic 
acid (24 h at room tem~rature) and resultant peptides separated by 
FPLC on Sepharose 12 (LKB/Pha~a~ia) in 70% formic acid. 
Pure peptides were analyzed for total composition in an LKBIPhar- 
macia Alpha Pius analyzer after acid hydrolysis with 6 M HCl/0.5% 
phenol for 24 h at 11O’C. Sequence degradations were performed with 
a Milligen ~os~quencer 6600 and an Applied Biosystems 12OA se- 
quencer, both equipped with an on-line analyzer. 
3. Results 
Co~ercially available cholesterol esterase from Can- 
dida cylindracea was purified as described in section 2, 
resulting in two active fractions co~esponding to a dimer 
and a monomer (Fig. l), respectively. Enzymes from 
these two fractions were treated separately to give three 
types of native crystals: triclinic (type II crystals; Table 
I) from the dimeric form (fraction 1 in Fig. i), mono- 
clinic (type I crystals, in the absence of substrate; Table 
I), and another triclinic {type III crystals; in the presence 
of 0.05 mM cholesterol inoleate; Table I) from the orig- 
inally monomeric form, fraction 2 in Fig. 1. In all crystal 
forms, the dimer is a basic entity of the enzyme. Appar- 
ently, the presence of the substrate added to the mono- 
meric enzyme shifts the equilibrium toward the dimeric 
state, the most active form of the enzyme, which then 
crystallizes as type III. 
The material correspon~ng to the type II and III crys- 
tals, grown from enzymes originally eluting as dimeric 
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Fig. 1. Exclusion chromatography on P-100 in 50 mM phosphate, pH 7.3, of cholesterol esterase from Candida cyl~dracea. Fractions 1 and 2 differ 
in size and correspond to a ~mer-monomer interrelationship. The insert shows SDS/polyacrylamide gel electrophoresis of redissolved crystals 
(according to Table I) of the material of the two fractions. 
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Fig. 2. Pinge~~nt compa~~n by HPLC of peptides produced by cleavage with Lys-C specific protease oftbe monomeric (top) and dimeric (bottom) 
fractions. As shown, no clearly differing peptides are noticed in either digest. 
Table I 
Properties of cholesterol esterase forms 
Type I III II 
Original form Monomer Dimer 
Fraction (Fig. 1) 2 1 
Substrate - Substrate + 
Crystal class Monoclinic Trichnic Trichnic 
Space group P2, PL Pl 
a (A) 122.9 58.84 58.565 
b (A) 101.0 90.93 88.685 
f (A) 95.2 58.74 58.S85 
a?) 90.0 93.39 93.29 
B(“) 108.3 105.74 113.82 
r(“) 90.0 97.22 95.98 
Cell volume (A3) 1,121,944 292,211 275,188 
Dimer/as~- 2 1 1 
metric unit 
Specific voiume 2.2 2.3 2.1 
(A3fDa) 
Diffraction limit 2.5 1.9 1.9 
(A) 
For types I and II, crystal data have also been given in [3]. 
Fig. 1) fractions, respectively, was used for sequence 
analysis after ~rbox~ethylation. 
Both types of material were treated with the Lys-spe- 
cific protease and the two digests were separated by re- 
verse phase HPLC. Peptide separations obtained, reveal 
identical patterns (Fig. 2). All peptide material from the 
monome~c pool was used for amino acid sequence anal- 
ysis, and most of the structures obtained were also 
checked by corresponding analysis of the dimeric pool. 
In no case were sequence differences found. This fact, 
together with the identical patterns (Fig. 2) and the crys- 
tal conversions (Table I) suggests that the two fractions 
have identical subunits. By similar separations of addi- 
tional digests, using Glu-specific and Asp-specific pro- 
teases, as well as CNBr, overlapping fragments were 
recovered from all parts of the protein molecule, estab- 
lishing an amino acid sequence consisting of 534 residues 
(Fig. 3). The primary structure is identical with that indi- 
rectly deduced from a co~esponding nucleotide se- 
quence (Lip 3 in [6]), except for a difference at one posi- 
tion, where we find Leu at position 350 instead of Ile [6]. 
Apparently, this corresponds to a microheterogeneity of 
conventional type between different strains. 
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Fig. 3. Primary structure ofcholesterol esterase from Candida cylindracea, together with a summary of anaLytical results for all peptides investigated. 
Peptide nomenclature: first letter (M or D) denotes origin from the monomeric and dimeric preparations, respectively; second letter denotes cleavage 
method, K for the Lys-C protease, E for the Glu-C protease, D for the N-Asp protease, and M for CNBr. Parts of peptides analyzed by sequencer 
degradations are indicated by solid lines, remaining parts, analyzed by total compositions only, by broken lines. The Ser-His-Glu catalytic triad is 
indicated by arrows, the four highly conserved Cys residues by asterisks, the microheterogeneity oward a DNA report [6] by double underlining, 
and the residues corresponding to CTG codons in the DNA (usually coding for Leu) but in Candida expected to code for Ser [4,q and now also 
directly proven to do so at all 15 positions by single underlining. 
4. Discussion 
4. I. monomeric and d~eric forms 
As shown in Fig. I, cholesterol esterase of Candida 
c~~indraceff separates into two fractions upon exclusion 
chromatography, corresponding to dimeric and mon- 
omeric forms respectively. They crystallize differently, 
the monomer as monoclinic crystals in the absence of 
substrate, or as triclinic crystals in the presence of 0.05 
mM cholesterol linoleate, whereas the dimer gives tri- 
clinic crystals (Table I). Although the two triclinic crystal 
forms as obtained from the dimeric fraction and, in the 
presence of linoleate, from the monomeric fraction are 
non-isomorphous with regard to the diffraction intensi- 
ties (Ghosh, D., unpublished). They differ slightly in unit 
cell parameters (Table I), the change of the monomer 
form from the monoclinic to the triclinic crystal type 
upon addition of substrate, suggests that apparently dif- 
ferent quaternary structures constitute reverseable dif- 
ferences, most likely associated with the presence of the 
substrate, which converts the enzyme into the active, 
dimeric form. This conclusion is supported further by the 
fingerprinting analysis (Fig. 2) which shows that the two 
fractions give identical elusion patterns of their Lys- 
cleaved products. Furthe~ore, sequence analysis of 
most fractions gave identical results. Combined, the data 
show that the monomeric and dimeric forms are derived 
from the same primary structure and explained by shifts 
in the equilibrium caused by the presence of the sub- 
strate, which promotes formation of the fully active, 
dimeric enzyme form. 
4.2. Primary sfrwture 
In addition to the peptides from the Lys-C protease 
digests mentioned above, further digests with Glu-C pro- 
tease, N-Asp protease, and CNBr were similarly ana- 
lyzed. Combined, they establish the entire structure of 
the protein by peptide analysis. As stated, it is based on 
analysis of both enzyme forms, with emphasis on the 
peptide from originally monomeric enzyme (the redis- 
solved type III crystals). The structure obtained (Fig. 3) 
has the same size as the other gene products of the mul- 
tiple genes for lipases from this organism, all giving 534 
residue polypeptide chains [6], and confining at the 
peptide level, the primary structure deduced from the 
corresponding cDNA structure. It also proves one resi- 
due difference, at position 350 which is now found to be 
Leu instead of Ile. Such a difference is fully compatible 
with strain differences, but establishes one further mi- 
croheterogeneity in this multigene enzyme family. Fi- 
nally, the present analysis is important in es~blishing 
that all the CTG positions in the gene are really occupied 
by Ser (as expected in Candida [4]) and not by Leu (which 
would be the universal alternative from that codon) as 
shown in Fig. 3. 
The structure obtained is fully compatible with all 
previous conclusions, showing a Ser-His-Glu catalytic 
triad [7,1X-16] at positions 209, 449, and 341 (Fig. 3), 
four conserved Cys residues at positions 60,97,268, and 
277, corresponding to disulphide bridges in the tertiary 
structures of the model enzymes [l l-161, and overall 
residue similarities toward the four other cholesterol 
esterases from Cundidu cylindracea at about the 80% 
level [7]. 
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